Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Pacific Sunwear F3Q08 (Qtr End 11/1/08) Earnings Call Transcript
- Mad Catz Interactive, Inc. F2Q09 (Qtr End 09/30/2008) Earnings Call Transcript
- Provectus Pharmaceuticals, Inc. The Wall Street Analyst Forum Call Transcript
- Point Blank Solutions, Inc. Q3 2008 (Quarter End 9/30/08) Earnings Call Transcript
- Navios Maritime Holdings Inc., Q3 2008 Earnings Call Transcript
- Gran Tierra Energy Inc. Q3 2008 (Qtr End 09/30/08) Earnings Call Transcript
- Oxygen Biotherapeutics, Inc. The Wall Street Analyst Forum Call Transcript
- ArvinMeritor, Inc. F4Q08 (Quarter End 9/28/08) Earnings Call Transcript
- Saks Incorporated Q3 2008 (Qtr End 11/01/08) Earnings Call Transcript
- Omega Navigation Enterprises, Inc. Q3 2008 Earnings Call Transcript
-
Editors' Picks
-
Most Popular
- My Reconsideration: Why Share Buybacks Are Pointless
- GM Could Benefit from Bankruptcy
- Throwing in the Towel on This Market?
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Full list of Editors' Picks »
- General Electric: Genuine Risk of Collapse? »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Peak Oil's Bell Is Ringing »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- The Pickens Plan Changes Its Strategy »
- Jim Rogers on China »
- Thornburg Mortgage, Inc. The Wall Street Analyst Call Transcript »
- The Biggest Problem Detroit's Big Three Face »
- Tech May Be a Wreck, But This Isn't 2001 »
- Wall Street Breakfast: Must-Know News »
- Precious Metals Will Depose Cash from Its Temporary Throne »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
mikehav
51 Comments
Pharmaceuticals: Pfizer Is a Buy
-global sales growth of 14.8% to $7.3 billion (B)
-pharmaceutical sales ($4.1B) growth of 16.7% led by Humira (a biological agent for autoimmune diseases such as rheumatoid arthritis), which experienced a 48% growth in sales for 1H08 at $1.1B with a forecast for sales of $4.3 billion for 2008
-medical product sales ($1.4B) growth of 14.7% driven by diagnostics sales ($0.9B) growth over 17%
-nutritional sales ($1.2B) growth of 21.3% thanks to strong results in emerging markets
Abbott Labs reported total sales for the first half of 2008 of $14.1B with $6.5B in the USA and $7.6B internationally. The Company posted a diversified mix of healthcare business units with 56.5% of sales from prescription drugs, 16.5% from nutrional products, 12.5% from diagnostics, and about 6.5% from vascular products such as stents. The Company increased its earnings-per-share guidance from a range of $3.20 - $3.25 to $3.24 - $3.28, excluding specified items, reflecting growth of about 15% along with expected sales growth in the mid-teens for the full year.
Pharmaceuticals: Pfizer Is a Buy
www.google.com/cse?cx=...
Carbon Allowance Futures Commence U.S. Trading
www.chicagoclimatex.co...
Trading on NYMEX Green Exchange:
nymex.greenfutures.com...
Global Carbon Trading Index - Updated
www.indexuniverse.com/...
ETF Trends on Carbon Trading:
www.etftrends.com/2008...
Hard Assets Investor.com on Carbon Trading:
www.hardassetsinvestor...
2-Year Chart for Climate Exchange (London: CLE):
finance.yahoo.com/q/bc...=
Global Carbon Trading Index - Updated
siteresources.worldban...
Climate Exchange: Uniquely Positioned to Benefit Carbon Credit Trading Expansion
However, while E*TRADE offers investors the opportunity to invest in foreign markets such as London and others; my own experience with this system is disappointing. First, strength in the US Dollar will impact investment returns since trading in the foreign markets only occurs in the local currency. Secondly, in my experience I was not able to place a trade online for the stocks and foreign markets that I attempted to place and had to call a broker for assistance, but he entered the order wrong and it was never filled. Finally, the currency conversion does not carry a commission, but you will not receive a favorable rate; so E*TRADE makes money on the spread between the real-time currency conversion ratio and what they offer to retail investors.
Since I no longer use my E*TRADE global account, I wrote the following article for a trading strategy for carbon credit companies:
mikehav.blogspot.com/2...
Bullish on Telcos
Cellcom Israel Ltd. announced that it has declared a cash dividend in the amount of NIS 2.76 per share, and in the aggregate amount of approximately NIS 270 million (the equivalent of approximately $0.77 per share and approximately $76 million in the aggregate, based on the representative rate of exchange on August 11, 2008; the actual $ amount for dividend paid in $ will be converted from NIS based upon the representative rate of exchange published by the Bank of Israel on September 4, 2008). The dividend will be payable to all of the Company's shareholders of record at the end of the trading day in the NYSE on August 25, 2008. The payment date will be September 8, 2008.
Cellcom Israel Ltd. announced that the Company's Board of Directors declared a cash dividend in the amount of NIS 2.65 per share, and in the aggregate amount of approximately NIS 258 million (the equivalent of approximately $0.77 per share and approximately $75 million in the aggregate, based on the representative rate of exchange on May 13, 2008; The actual $ amount for dividend paid in $ will be converted from NIS based upon the representative rate of exchange published by the Bank of Israel on June 4, 2008). The dividend will be payable to all of the Company's shareholders of record at the end of the trading day in the NYSE on May 27, 2008. The payment date will be June 10, 2008.
Reuters reported that Cellcom Israel Ltd.'s Board declared a cash dividend of ILS7.18 per share ($2.10) or a total of ILS700 million to be paid on April, 14. This includes a dividend for the fourth quarter of ILS1.78 per share and a one-time extraordinary dividend for the year of ILS5.4 per share.
Cellcom Israel Ltd. announced that it has declared a cash dividend in the amount of NIS 2.06 per share, and in the aggregate amount of approximately NIS 201 million, the dividend will be payable to all shareholders of record at the end of the trading day in the NYSE on August 23, 2007. The payment date will be September 6, 2007.
A Global Transport ETF Strategy
mikehav.blogspot.com/2...
A Leveraged Investment Vehicle for the Global Rail Industry
mikehav.blogspot.com/2...
A Global Transport ETF Strategy
Carbon Prices Fall Along with Oil and Other Commodities
5 Stock Market ETFs that Have Defied the Bear Market
Bullish on Telcos
A New Way for Investors to Sail the Seas
NationCapShares: An ETF Idea for Developed, Emerging and Frontier Markets